(Q42656778)

4 November 2017

Monitoring of large randomised clinical trials: a new approach with Bayesian methods (English)

1 reference

4 November 2017

1

M K Parmar

1 reference

4 November 2017

2

G O Griffiths

1 reference

4 November 2017

3

D J Spiegelhalter

1 reference

4 November 2017

4

R L Souhami

1 reference

4 November 2017

5

D G Altman

1 reference

4 November 2017

E van der Scheuren

6

1 reference

PubMed ID

11502318

4 November 2017

CHART steering committee

series ordinal

7

1 reference

PubMed ID

11502318

4 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

4 November 2017

1 reference

4 November 2017

358

1 reference

4 November 2017

9279

1 reference

4 November 2017

375-381

1 reference

A Multiple Testing Procedure for Clinical Trials

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Interim analysis: the alpha spending function approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Applying Bayesian ideas in drug development and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Tutorial in biostatistics Bayesian data monitoring in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Data and safety monitoring in the Concorde and Alpha trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

Data monitoring committees and interim monitoring guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

The agonising negative trend in monitoring of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905558-1

7 January 2021

10.1016/S0140-6736(01)05558-1

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

11502318